🇺🇸 FDA
Pipeline program

blood sampling

AMD-CCR-2024-02

Unknown other active

Quick answer

blood sampling for Screening for Colon Cancer is a Unknown program (other) at Marker Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Marker Therapeutics
Indication
Screening for Colon Cancer
Phase
Unknown
Modality
other
Status
active

Clinical trials